CI Investments Inc
NVAX icon

CI Investments Inc’s Novavax NVAX Stock Holding History

CI Investments Inc’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,256
Closed -$45K – 1313
2023
Q3 		$45K Sell
6,256
-187
-3% -$1.49K ﹤0.01% 990
2023
Q2 		$48K Buy
6,443
+2,743
+74% +$21.6K ﹤0.01% 960
2023
Q1 		$26K Sell
3,700
-47
-1% -$432 ﹤0.01% 1029
2022
Q4 		$39K Buy
3,747
+3,523
+1,573% +$62.2K ﹤0.01% 984
2022
Q3 		$4K Sell
224
-16
-7% -$693 ﹤0.01% 1167
2022
Q2 		$12K Sell
240
-2,058
-90% -$107K ﹤0.01% 1029
2022
Q1 		$169K Buy
2,298
+1,900
+477% +$169K ﹤0.01% 747
2021
Q4 		$57K Buy
398
+76
+24% +$13.1K ﹤0.01% 989
2021
Q3 		$67K Buy
+322
New +$71K ﹤0.01% 934
2021
Q2 		– Sell
-4,092
Closed -$742K – 1069
2021
Q1 		$742K Buy
+4,092
New +$815K ﹤0.01% 444

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CI Investments Inc's NVAX Position: Q4 2023 in Review

CI Investments Inc sold out of Novavax (NVAX) in Q4 2023, closing a stake of 6,256 shares — an estimated $45K sold.

CI Investments Inc first reported a position in NVAX in Q1 2021 and held it in 10 quarters. The position peaked at $742K in Q1 2021. 199 funds tracked by Wall St. Rank hold NVAX as of Q4 2023.

  • CI Investments Inc reported no remaining Novavax position as of Q4 2023 after selling out during the quarter.
  • CI Investments Inc sold 6,256 Novavax shares in Q4 2023, an estimated $45K.
  • CI Investments Inc first reported a position in Novavax in Q1 2021 and held it in 10 quarters.
  • CI Investments Inc's Novavax position peaked at $742K in Q1 2021.
  • 199 funds tracked by Wall St. Rank held Novavax as of Q4 2023.

Based on CI Investments Inc's 13F filing for Q4 2023, filed 12 Feb 2024.